经济负担数据的计算与应用。
The calculation and use of economic burden data.
作者信息
Frick K D, Kymes S M
出版信息
Br J Ophthalmol. 2006 Mar;90(3):255-7. doi: 10.1136/bjo.2005.084848.
Abstract
Even in a developed economy, visual impairment can limit further economic development
摘要
即使在发达经济体中，视力障碍也会限制进一步的经济发展。
相似文献
1
The calculation and use of economic burden data.经济负担数据的计算与应用。
Br J Ophthalmol. 2006 Mar;90(3):255-7. doi: 10.1136/bjo.2005.084848.
2
An estimation of the worldwide economic and health burden of visual impairment.视觉障碍的全球经济和健康负担估计。
Glob Public Health. 2012;7(5):465-81. doi: 10.1080/17441692.2011.634815. Epub 2011 Dec 5.
3
The economic impact and cost of visual impairment in Australia.澳大利亚视力损害的经济影响与成本。
Br J Ophthalmol. 2006 Mar;90(3):272-5. doi: 10.1136/bjo.2005.080986.
4
Cost utility for penetrating keratoplasty in patients with poor binocular vision.双眼视力差的患者穿透性角膜移植术的成本效用
Ophthalmology. 2006 Dec;113(12):2176-80. doi: 10.1016/j.ophtha.2006.05.060. Epub 2006 Sep 25.
5
The cost of visual impairment: purposes, perspectives, and guidance.视力损害的代价：目的、观点与指南
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1801-5. doi: 10.1167/iovs.09-4469. Epub 2010 Jan 13.
6
The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.原发性开角型青光眼患者医疗服务成本增加：决策分析方法。
Am J Ophthalmol. 2010 Jul;150(1):74-81. doi: 10.1016/j.ajo.2010.01.037. Epub 2010 May 20.
7
The economic burden of major adult visual disorders in the United States.美国主要成人视觉障碍的经济负担。
Arch Ophthalmol. 2006 Dec;124(12):1754-60. doi: 10.1001/archopht.124.12.1754.
8
How much is the cost of visual impairment: caveat emptor.视力损害的代价几何： buyer beware（买者自负） 。
Pharmacoeconomics. 2006;24(2):207-9; discussion 210. doi: 10.2165/00019053-200624020-00008.
9
Costs of interventions for visual impairment.视力损害干预措施的成本。
Am J Ophthalmol. 2007 Apr;143(4):561-5. doi: 10.1016/j.ajo.2006.10.055. Epub 2006 Dec 8.
10
The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia.全球未矫正老视导致的潜在生产力损失负担。
Ophthalmology. 2015 Aug;122(8):1706-10. doi: 10.1016/j.ophtha.2015.04.014.
引用本文的文献
1
Systematic review and meta-synthesis of coping with retinitis pigmentosa: implications for improving quality of life.系统评价和元综合应对色素性视网膜炎：提高生活质量的意义。
BMC Ophthalmol. 2019 Aug 13;19(1):181. doi: 10.1186/s12886-019-1169-z.
本文引用的文献
1
What is a life worth? Robustness of VSL values from contingent valuation surveys.生命的价值何在？条件价值评估调查中VSL值的稳健性。
Risk Anal. 2005 Aug;25(4):783-800. doi: 10.1111/j.1539-6924.2005.00646.x.
2
Analysis of costs and benefits of the Gambian Eye Care Program.冈比亚眼保健项目的成本效益分析。
Arch Ophthalmol. 2005 Feb;123(2):239-43. doi: 10.1001/archopht.123.2.239.
3
What is the cost of blindness?失明的代价是什么？
Br J Ophthalmol. 2003 Oct;87(10):1201-4. doi: 10.1136/bjo.87.10.1201.
4
Willingness to pay for a quality-adjusted life year: in search of a standard.为质量调整生命年支付意愿：探寻一种标准。
Med Decis Making. 2000 Jul-Sep;20(3):332-42. doi: 10.1177/0272989X0002000310.
5
On valuing morbidity, cost-effectiveness analysis, and being rude.
J Health Econ. 1997 Dec;16(6):749-57. doi: 10.1016/s0167-6296(97)00027-1.
Zotero 插件